Albatera, Khlaer Eve Anekha .

HRN: 21-35-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2026
CEFUROXIME 750MG (VIAL)
05/05/2026
05/12/2026
IV
413mg
Q8
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: